Zai Lab

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zai Lab and other ETFs, options, and stocks.

About ZLAB

Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra.

CEO

Ying Du

CEOYing Du

Employees

1,869

Employees1,869

Headquarters

Shanghai, Shanghai

HeadquartersShanghai, Shanghai

Founded

2014

Founded2014

Employees

1,869

Employees1,869

ZLAB Key Statistics

Market cap

3.96B

Market cap3.96B

Price-Earnings ratio

-17.08

Price-Earnings ratio-17.08

Dividend yield

—

Dividend yield—

Average volume

843.35K

Average volume843.35K

High today

$35.32

High today$35.32

Low today

$34.01

Low today$34.01

Open price

$34.01

Open price$34.01

Volume

627.41K

Volume627.41K

52 Week high

$44.34

52 Week high$44.34

52 Week low

$16.01

52 Week low$16.01

ZLAB News

Seeking Alpha 2d

Zai Lab reaffirms $560M-$590M 2025 revenue target as VYVGART and pipeline drive growth

Earnings Call Insights Zai Lab reaffirms $560M-$590M 2025 revenue target as VYVGART and pipeline drive growth Aug. 07, 2025 10:30 PM ET Zai Lab Limited (ZLAB) S...

Analyst ratings

85%

of 13 ratings

Buy

84.6%

Hold

15.4%

Sell